Joining two investment groups in a leap of faith, Jack Schuler just placed a $1.85 million dollar bet in late December…
And it’s already paying off!
But his early gains of 39% ($720,000) could be the very tip of the iceberg, and YOU could follow his lead!
So what is this million-dollar bet? Why is 1 man prepared to risk so much? How can I profit from this situation?
If you’re asking those questions, you’re certainly in the right state of mind. And you already have the upper hand on the majority of people who sit around and wait for ‘luck’ to give them everything they want.
To get straight to the point, Schuler recently purchased $1.85 million worth of stock in Vermillion, Inc. (VRML) at $1.44 per share.
As a 10% owner of the company now, he is riding on the belief that VRML is headed up—which would be a turnaround for the biopharmaceutical company.
This insider play is very interesting on 2 fronts…
1st of all, VRML is a cancer-fighting company attempting to enhance the treatment of ovarian cancer on the back of its OVA1 screening test for the disease.
But VRML had recently been struggling, and the capital raised from Schuler and others was necessary to keep the doors open for this company.
The 2nd part of the equation is that the new investors’ bet is already paying off in a huge way.
After buying the stock at $1.44 a share, VRML has jumped up to the $2 mark and stayed in that general vicinity.
For Schuler, that rise equated roughly to ($720,000) in profits so far, which could be the very beginning of VRML’s climb.
Now, VRML has just reached above its long-term moving average, but that indicator is still pointed downward. Should it reverse and turn up thanks to continued performance from this stock, I would consider VRML a buy.
If that happens, readers of my Penny Stock Insider newsletter will be the first to know.
